These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8522324)

  • 1. Localization of the CDKN4/p27Kip1 gene to human chromosome 12p12.3.
    Martin E; Cacheux V; Cavé H; Lapierre JM; Le Paslier D; Grandchamp B
    Hum Genet; 1995 Dec; 96(6):668-70. PubMed ID: 8522324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1.
    Cavé H; Gérard B; Martin E; Guidal C; Devaux I; Weissenbach J; Elion J; Vilmer E; Grandchamp B
    Blood; 1995 Nov; 86(10):3869-75. PubMed ID: 7579355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.
    Tanaka C; Yoshimoto K; Yang P; Kimura T; Yamada S; Moritani M; Sano T; Itakura M
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3141-7. PubMed ID: 9284759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.
    Hatta Y; Takeuchi S; Yokota J; Koeffler HP
    Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and characterization of the human p27Kip1 gene promoter.
    Minami S; Ohtani-Fujita N; Igata E; Tamaki T; Sakai T
    FEBS Lett; 1997 Jul; 411(1):1-6. PubMed ID: 9247132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Toyoshima H; Hunter T
    Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.
    Wolf G; Schroeder R; Zahner G; Stahl RA; Shankland SJ
    Am J Pathol; 2001 Mar; 158(3):1091-100. PubMed ID: 11238057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Lee MH; Reynisdóttir I; Massagué J
    Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas.
    Ferrando AA; Balbín M; Pendás AM; Vizoso F; Velasco G; López-Otín C
    Hum Genet; 1996 Jan; 97(1):91-4. PubMed ID: 8557269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
    Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
    Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
    Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
    Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a polymorphism in the coding region of the p27Kip1 gene.
    Cavé H; Martin E; Devaux I; Grandchamp B
    Ann Genet; 1995; 38(2):108. PubMed ID: 7486826
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
    Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle.
    Coats S; Flanagan WM; Nourse J; Roberts JM
    Science; 1996 May; 272(5263):877-80. PubMed ID: 8629023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27KIP1 deletions in childhood acute lymphoblastic leukemia.
    Komuro H; Valentine MB; Rubnitz JE; Saito M; Raimondi SC; Carroll AJ; Yi T; Sherr CJ; Look AT
    Neoplasia; 1999 Aug; 1(3):253-61. PubMed ID: 10935480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest.
    Nishi K; Schnier JB; Bradbury EM
    Exp Cell Res; 1998 Sep; 243(2):222-31. PubMed ID: 9743582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of rat p27Kip1, a cyclin-dependent kinase inhibitor.
    Nomura H; Sawada Y; Fujinaga K; Ohtaki S
    Gene; 1997 Jun; 191(2):211-8. PubMed ID: 9218722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.